ATE115856T1 - Kosmetische verwendung eines mittels gegen erytheme. - Google Patents

Kosmetische verwendung eines mittels gegen erytheme.

Info

Publication number
ATE115856T1
ATE115856T1 AT91402808T AT91402808T ATE115856T1 AT E115856 T1 ATE115856 T1 AT E115856T1 AT 91402808 T AT91402808 T AT 91402808T AT 91402808 T AT91402808 T AT 91402808T AT E115856 T1 ATE115856 T1 AT E115856T1
Authority
AT
Austria
Prior art keywords
cosmetic use
nadp
nad
against erythema
dinucleotide
Prior art date
Application number
AT91402808T
Other languages
English (en)
Inventor
Paolo Giacomoni
Jean-Luc Morancais
Alain Lety
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE115856T1 publication Critical patent/ATE115856T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT91402808T 1990-10-30 1991-10-22 Kosmetische verwendung eines mittels gegen erytheme. ATE115856T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9013437A FR2668366B1 (fr) 1990-10-30 1990-10-30 Utilisation cosmetique d'une composition ayant une activite antierythemale et composition correspondante.

Publications (1)

Publication Number Publication Date
ATE115856T1 true ATE115856T1 (de) 1995-01-15

Family

ID=9401699

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91402808T ATE115856T1 (de) 1990-10-30 1991-10-22 Kosmetische verwendung eines mittels gegen erytheme.

Country Status (8)

Country Link
US (1) US5250290A (de)
EP (1) EP0484199B1 (de)
JP (1) JP3489082B2 (de)
AT (1) ATE115856T1 (de)
CA (1) CA2054475A1 (de)
DE (1) DE69106110T2 (de)
ES (1) ES2065647T3 (de)
FR (1) FR2668366B1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5690944A (en) * 1994-12-20 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing lactate dehydrogenase inhibitors
DE19545107A1 (de) * 1995-12-04 1997-06-05 Beiersdorf Ag Verwendung eines wirksamen Gehaltes an Adenosin in kosmetischen oder dermatologischen Zubereitungen
JP2000506121A (ja) * 1996-02-16 2000-05-23 マツクス―プランク―ゲゼルシヤフト ツール フエルデルング デル ヴイツセンシヤフテン エー フアウ ホスファチジルオリゴグリセリン
DE19622224A1 (de) 1996-02-16 1997-08-21 Max Planck Gesellschaft Phosphatidyloligoglycerine
DE19723778A1 (de) * 1997-06-06 1998-12-10 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Mono-Di- und/oder Trialkylestern der Phosphorsäure
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
US6337065B1 (en) 1998-12-01 2002-01-08 University Of Kentucky Research Foundation Method for enhancing protective cellular responses to genotoxic stress in skin
EP1342462B1 (de) * 2000-11-22 2007-04-11 Otsuka Pharmaceutical Co., Ltd. Öl-in-wasser-emulsionszusammensetzung und verfahren zu ihrer herstellung
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
JP2008094813A (ja) * 2006-10-16 2008-04-24 Naris Cosmetics Co Ltd 抗老化皮膚組成物
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
CN105497055B (zh) * 2014-09-24 2018-05-08 上海交通大学 烟酰胺腺嘌呤二核苷酸在制备防治皮肤辐射损伤药物中的应用
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597367B1 (fr) * 1986-04-22 1988-07-15 Oreal Procede pour faciliter la formation de spherules lipidiques en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.
EP0256472A3 (de) * 1986-08-11 1988-09-07 Lion Corporation Kosmetische Mittel zur Anwendung auf der Haut
US4767741A (en) * 1986-08-15 1988-08-30 Avon Products, Inc. Two-phase liquid cosmetic and method of preparing same
JPH075477B2 (ja) * 1988-12-28 1995-01-25 テルモ株式会社 ヘモグロビン含有リポソームおよびその製法
US5073296A (en) * 1990-04-17 1991-12-17 Isp Investments Inc. Preparation of discrete microdroplets of an oil in water
US5063057A (en) * 1990-09-26 1991-11-05 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic capsules
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules

Also Published As

Publication number Publication date
ES2065647T3 (es) 1995-02-16
FR2668366B1 (fr) 1993-01-29
JPH0624953A (ja) 1994-02-01
JP3489082B2 (ja) 2004-01-19
FR2668366A1 (fr) 1992-04-30
EP0484199B1 (de) 1994-12-21
US5250290A (en) 1993-10-05
DE69106110D1 (de) 1995-02-02
CA2054475A1 (fr) 1992-05-01
DE69106110T2 (de) 1995-08-10
EP0484199A1 (de) 1992-05-06

Similar Documents

Publication Publication Date Title
ATE115856T1 (de) Kosmetische verwendung eines mittels gegen erytheme.
DE69504567D1 (de) Verwendung eines Antagonisten der Substanz P in einer kosmetischen Zusammensetzung und erhaltene Zusammensetzung
AU2211992A (en) Cosmetic composition
DE69418214T2 (de) Cyclopentan(penten)-hepten-oder heptansäuren und deren derivate als therapeutische wirkstoffe
GR3036636T3 (en) Novel rhodamine derivatives for photodynamic therapy of cancer and in vitro purging of the leukemias
DE69629721D1 (de) Carnamoyloxy derivate von mutilin und deren verwendung als antibakterielles mittels
DE69902131D1 (de) Kosmetische und/oder dermatologische Zusammensetzung enthaltend Salicylsäure oder ihre Derivate und ihre Verwendung
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
AU674142B2 (en) Use of cosmetic composition
GB2286121A (en) Use of an ecdysteroid in cosmetics or dermatology
ATE221376T1 (de) Verwendung von nmifa als entzündungshemmer in oberflächlichem saugetier-gewebe
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
DK0565519T3 (da) Illudinanaloge som antitumormidler
EP0449099A3 (en) Retinoide derivatives, their preparation and their use for medicaments
IT1252061B (it) Composizioni per uso dermatologico e cosmetico
DE69526350D1 (de) Abschuppungs-zusammensetzung
DE59106201D1 (de) Dermatologische Zusammensetzungen mit einem Gehalt an cis-Urocaninsäure.
DE69322252T2 (de) Formulierung und verwendung von carotenoiden in der krebsbehandlung
ATE262886T1 (de) Hautschutzzubereitung
FI920906A0 (fi) Foerfaranden foer foerebyggande och minskande av aerrskador.
ATE113828T1 (de) Kosmetische zusammensetzung.
AU9034291A (en) Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
ATE54413T1 (de) In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.
ATE302591T1 (de) Kosmetische oder dermatologische lichtschutzzubereitungen mit einem gehalt an dioctylbutamidotriazon und einem oder mehreren polyolen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties